Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/216237
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Mode of action of a formulation containing hydrazones and saponins against leishmania spp. Role in mitochondria, proteases and reinfection process

AutorUpegui, Yulieth A.; Echeverri, Fernando; Quiñones, Winston; Torres, Fernando; Nácher-Vázquez, Montserrat CSIC ORCID; Rivas, Luis CSIC ORCID ; dos Santos Meira, Camila; Gedamu, Lashitew; Escobar, Gustavo; Archbold, Rosendo; Vélez, Ivan D.; Robledo, Sara M.
Palabras claveChromane hydrazone
Leishmania braziliensis
L. pifanoi
Sapindus saponaria
ATP level
Mitochondria
Proteases
Morphology
Reinfection process
Fecha de publicación26-jun-2020
EditorElsevier
CitaciónInternational Journal for Parasitology: Drugs and Drug Resistance 13: 94-106 (2020)
ResumenToxicity and poor adherence to treatment that favors the generation of resistance in the Leishmania parasites highlight the need to develop better alternatives. Here, we evaluated the in vitro effectiveness of hydrazone derived from chromanes 2-(2,3-dihydro-4H-1-benzothiopyran-4-ylidene) hydrazide (TC1) and 2-(2,3-dihydro- 4H-1-benzopyran-4-ylidene) hydrazide (TC2) and the mixture of triterpene saponin hederagenin-3-O-(3,4-Odiacetyl-ß-D-xylopyranosyl-(1à3)-a-L- rhamnopyranosyl-(1à2)-a-L-arabinofuranoside, hederagenin-3-O-(3,4-Odiacetyl-a-L- arabinopyranosyl-(1à3)-a-L-rhamnopyranosyl-(1à2)-a-L-arabinofuranoside and, hederagenin-3-O-(4-O-acetyl-ß-D-xylopyranosyl-(1à3)-a-L-rhamnopyranosyl-(1à2)-a-L-arabinofuranoside from Sapindus saponaria(SS) on L. braziliensis and L. pifanoi. Mixtures of TC1 or TC2 with saponin were formulated for topical application and the therapeutic effectiveness was evaluated in the model for cutaneous leishmaniasis (CL) in golden hamster.The mode of action of these compounds was tested on various parasite processes and ultrastructural parasite modifications. TC1, TC2 and SS showed moderate cytotoxicity when tested independently but toxicity was improved when tested in combination. The compounds were more active against intracellular Leishmania amastigotes. In vivo studies showed that combinations of TC1 or TC2 with SS in 1:1 ratio (w/w) cured 100% of hamsters with no signs associated with toxicity. The compounds did cause changes in the mitochondrial activity of the parasite with a decrease in ATP levels and depolarization of membrane potential and overproduction of reactive oxygen species; nevertheless, these effects were not related to alterations in membrane permeability.The phagolysosome ultrastructure was also affected impacting the survival of Leishmania but the function of the lysosome nor the pH inside the phagolysosome did not change.Lastly, there was a protease inhibition which was directly related to the decrease in the ability of Leishmania to infect and multiply inside the macrophage. The results suggest that the combination of TC1 and TC2 with SS in a 1:1 ratio is capable of curing CL in hamsters.This effect may be due to the ability of these compounds to affect parasite survival and the ability to infect new cells.
Descripción13 p.-8 fig.-3 tab.
Versión del editorhttps://doi.org/10.1016/j.ijpddr.2020.06.004
URIhttp://hdl.handle.net/10261/216237
DOI10.1016/j.ijpddr.2020.06.004
E-ISSN2211-3207
Aparece en las colecciones: (CIB) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
International Journal for Parasitology Drugs and Drug Resistance_ Upegui Zapata_2020.pdfArtículo principal2,71 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

6
checked on 15-abr-2024

SCOPUSTM   
Citations

12
checked on 11-abr-2024

WEB OF SCIENCETM
Citations

12
checked on 26-feb-2024

Page view(s)

149
checked on 15-abr-2024

Download(s)

124
checked on 15-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons